INMUNE BIO INC. Basic Shares Outstanding (Weighted Average)
INMUNE BIO INC. (INMB) reported Basic Shares Outstanding (Weighted Average) of 26.72 million shares for the 3-month period ending 2026-06-30, per its 10-Q filed 2026-08-06.
Financial Statements › Income Statement › Earnings Per Share
us-gaap:WeightedAverageNumberOfSharesOutstandingBasic · last filed 2026-08-06
- INMUNE BIO INC. weighted average number of shares outstanding, basic for the quarter ending 2026-06-30 was 26.72M shares, a 14.68% increase year-over-year.
- INMUNE BIO INC. weighted average number of shares outstanding, basic for the quarter ending 2026-03-31 was 26.59M shares, a 18.18% increase year-over-year.
- INMUNE BIO INC. weighted average number of shares outstanding, basic for the quarter ending 2025-12-31 was 26.61M shares, a 19.59% increase year-over-year.
- INMUNE BIO INC. weighted average number of shares outstanding, basic for the quarter ending 2025-09-30 was 26.59M shares, a 31.70% increase year-over-year.
- INMUNE BIO INC. weighted average number of shares outstanding, basic for fiscal 2025 was 24.76M shares, a 24.13% increase from fiscal 2024.
- INMUNE BIO INC. weighted average number of shares outstanding, basic for fiscal 2024 was 19.94M shares, a 10.92% increase from fiscal 2023.
- INMUNE BIO INC. weighted average number of shares outstanding, basic for fiscal 2023 was 17.98M shares, a 0.30% increase from fiscal 2022.
- INMUNE BIO INC. weighted average number of shares outstanding, basic for fiscal 2022 was 17.93M shares, a 11.14% increase from fiscal 2021.
| Period end | Weighted Average Number of Shares Outstanding, Basic 3 month | Weighted Average Number of Shares Outstanding, Basic 6 month | Weighted Average Number of Shares Outstanding, Basic 9 month | Weighted Average Number of Shares Outstanding, Basic 12 month |
|---|---|---|---|---|
| 2026-06-30 | 26.72M shares 10-Q · filed 2026-08-06 | 26.65M shares 10-Q · filed 2026-08-06 | 26.64M shares derived: average of 3 quarters · filed 2026-08-06 | 26.62M shares derived: average of 4 quarters · filed 2026-08-06 |
| 2026-03-31 | 26.59M shares 10-Q · filed 2026-05-07 | 26.60M shares derived: average of 2 quarters · filed 2026-05-07 | 26.59M shares derived: average of 3 quarters · filed 2026-05-07 | 25.77M shares derived: average of 4 quarters · filed 2026-08-06 |
| 2025-12-31 | 26.61M shares derived: 10-K 12 month − 10-Q 9 month · filed 2026-03-30 | 26.60M shares derived: average of 2 quarters · filed 2026-03-30 | 25.50M shares derived: average of 3 quarters · filed 2026-08-06 | 24.76M shares 10-K · filed 2026-03-30 |
| 2025-09-30 | 26.59M shares 10-Q · filed 2025-10-30 | 24.94M shares derived: average of 2 quarters · filed 2026-08-06 | 24.14M shares 10-Q · filed 2025-10-30 | 23.66M shares derived: average of 4 quarters · filed 2026-08-06 |
| 2025-06-30 | 23.30M shares 10-Q · filed 2026-08-06 | 22.90M shares 10-Q · filed 2026-08-06 | 22.68M shares derived: average of 3 quarters · filed 2026-08-06 | 22.06M shares derived: average of 4 quarters · filed 2026-08-06 |
| 2025-03-31 | 22.50M shares 10-Q · filed 2026-05-07 | 22.37M shares derived: average of 2 quarters · filed 2026-05-07 | 21.64M shares derived: average of 3 quarters · filed 2026-05-07 | 21.06M shares derived: average of 4 quarters · filed 2026-05-07 |
| 2024-12-31 | 22.25M shares derived: 10-K 12 month − 10-Q 9 month · filed 2026-03-30 | 21.22M shares derived: average of 2 quarters · filed 2026-03-30 | 20.58M shares derived: average of 3 quarters · filed 2026-03-30 | 19.94M shares 10-K · filed 2026-03-30 |
| 2024-09-30 | 20.19M shares 10-Q · filed 2025-10-30 | 19.75M shares derived: average of 2 quarters · filed 2025-10-30 | 19.18M shares 10-Q · filed 2025-10-30 | 18.89M shares derived: average of 4 quarters · filed 2025-10-30 |
| 2024-06-30 | 19.31M shares 10-Q · filed 2025-08-07 | 18.67M shares 10-Q · filed 2025-08-07 | 18.45M shares derived: average of 3 quarters · filed 2025-08-07 | 18.34M shares derived: average of 4 quarters · filed 2025-08-07 |
| 2024-03-31 | 18.03M shares 10-Q · filed 2025-05-08 | 18.02M shares derived: average of 2 quarters · filed 2025-05-08 | 18.02M shares derived: average of 3 quarters · filed 2025-05-08 | 18.00M shares derived: average of 4 quarters · filed 2025-05-08 |
| 2023-12-31 | 18.02M shares derived: 10-K 12 month − 10-Q 9 month · filed 2025-03-27 | 18.02M shares derived: average of 2 quarters · filed 2025-03-27 | 17.99M shares derived: average of 3 quarters · filed 2025-03-27 | 17.98M shares 10-K · filed 2025-03-27 |
| 2023-09-30 | 18.01M shares 10-Q · filed 2024-10-31 | 17.98M shares derived: average of 2 quarters · filed 2024-10-31 | 17.97M shares 10-Q · filed 2024-10-31 | 17.96M shares derived: average of 4 quarters · filed 2024-10-31 |
| 2023-06-30 | 17.95M shares 10-Q · filed 2024-08-01 | 17.95M shares 10-Q · filed 2024-08-01 | 17.95M shares derived: average of 3 quarters · filed 2024-08-01 | 17.95M shares derived: average of 4 quarters · filed 2024-08-01 |
| 2023-03-31 | 17.95M shares 10-Q · filed 2024-05-09 | 17.95M shares derived: average of 2 quarters · filed 2024-05-09 | 17.95M shares derived: average of 3 quarters · filed 2024-05-09 | 17.95M shares derived: average of 4 quarters · filed 2024-05-09 |
| 2022-12-31 | 17.95M shares derived: 10-K 12 month − 10-Q 9 month · filed 2024-03-28 | 17.95M shares derived: average of 2 quarters · filed 2024-03-28 | 17.95M shares derived: average of 3 quarters · filed 2024-03-28 | 17.93M shares 10-K · filed 2024-03-28 |
| 2022-09-30 | 17.95M shares 10-Q · filed 2023-11-01 | 17.95M shares derived: average of 2 quarters · filed 2023-11-01 | 17.92M shares 10-Q · filed 2023-11-01 | 17.91M shares derived: average of 4 quarters · filed 2023-11-01 |
| 2022-06-30 | 17.95M shares 10-Q · filed 2023-08-07 | 17.91M shares 10-Q · filed 2023-08-07 | 17.89M shares derived: average of 3 quarters · filed 2023-08-07 | 17.75M shares derived: average of 4 quarters · filed 2023-08-07 |
| 2022-03-31 | 17.87M shares 10-Q · filed 2023-05-03 | 17.87M shares derived: average of 2 quarters · filed 2023-05-03 | 17.69M shares derived: average of 3 quarters · filed 2023-05-03 | 17.01M shares derived: average of 4 quarters · filed 2023-05-03 |
| 2021-12-31 | 17.86M shares derived: 10-K 12 month − 10-Q 9 month · filed 2023-03-02 | 17.60M shares derived: average of 2 quarters · filed 2023-03-02 | 16.72M shares derived: average of 3 quarters · filed 2023-03-02 | 16.13M shares 10-K · filed 2023-03-02 |
| 2021-09-30 | 17.33M shares 10-Q · filed 2022-11-02 | 16.15M shares derived: average of 2 quarters · filed 2022-11-02 | 15.55M shares 10-Q · filed 2022-11-02 | |
| 2021-06-30 | 14.97M shares 10-Q · filed 2022-08-03 | 14.65M shares 10-Q · filed 2022-08-03 | ||
| 2021-03-31 | 14.32M shares 10-Q · filed 2022-05-05 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| ImageneBio, Inc. (IMA) | United States | $0.056B | -1.31 |
| BioAtla, Inc. (BCAB) | United States | $0.058B | -0.21 |
| EXOZYMES INC. (EXOZ) | United States | $0.058B | |
| Tevogen Inc. (TVGN) | United States | $0.049B | |
| MiNK Therapeutics, Inc. (INKT) | United States | $0.063B | -5.37 |
| Instil Bio, Inc. (TIL) | United States | $0.048B | -1.73 |
| LeonaBio, Inc. (LONA) | United States | $0.047B | -0.61 |
| Eloxx Pharmaceuticals, Inc. (ELOX) | United States | $0.065B | |
| Metagenomi Therapeutics, Inc. (MGX) | United States | $0.044B | -0.48 |
| BioStem Technologies, Inc. (BSEM) | United States | $0.069B |